ProDisc-C total disc arthroplasty vs ACDF in single-level cervical disc disease at 7 years .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease: Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption Study
J Bone Joint Surg Am. 2015 Nov 4;97(21):1738-47209 patients with single-level cervical degenerative disc disease were randomized to undergo either anterior cervical discectomy and fusion (ACDF) or total disc arthroplasty (with ProDisc-C). The purpose of this randomized controlled trial was to report the 7-year efficacy and safety outcomes of an FDA Investigational Device Exemption randomized controlled trial. The results at both 2 and 7 years postoperatively demonstrated that both procedures were effective in reducing neck and arm pain, and in improving and maintaining function and health related quality of life, with no significant differences between groups. Patient satisfaction, the rate of neurologic success, medication usage, and adverse events were similar between groups. Significantly more secondary surgical procedures were performed in the ACDF group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
